Maryland, 3 Jan 2025: FDA published a draft guidance document on Jan. 2, 2025 that provides considerations for complying with 21 Code of Federal Regulations (CFR) 211.110 (1). This specific section of the CFR focuses on production and process c......
View Details

Related News

• First ayurvedic diagnostic device 'Nadi Tarangini', gets CDSCO nod (06-01-2025)

---

• ITRI Unveils Advanced Smart Medical Technology at CES 2025 (06-01-2025)

---

• MTal Gears up for MedTekon (06-01-2025)

---

• Medical store operator arrested with drug Injections and Tablets (06-01-2025)

---

• CDRI research a ray of hope for triple negative breast cancer patients (06-01-2025)

---

• CDSCO releases draft standard evaluation protocols for issuing license for IVDs (06-01-2025)

---

• Complaints filed with FDA and CMO against Solapur Ayush manufacturer; owner refutes allegations (05-01-2025)

---

• MP FDA forms joint team with Centre to ensure revised Schedule M compliance in pharma cos (05-01-2025)

---

• Draft notification for extension of Schedule M published for comments (04-01-2025)

---

• Illegal medical shop busted in Hyderabad (04-01-2025)

---